Global Cardiac Resynchronization Therapy Pacemaker Market Analysis, 2016-2020

Report : Global Cardiac Resynchronization Therapy Pacemaker Market 2016-2020 is a new market research publication announced by Reportstack.

Report Outline: CRT-Ps are an advanced implantable form of conventional pacemakers. They help the heart function efficiently by monitoring its signals and coordinating with the ventricles to contract at the same time. These devices resynchronize the heart's rhythm to improve breathlessness and fatigue, and avoid dizziness and fainting in individuals. 

Physicians surgically implant the CRT-P under the skin, below the collarbone. They connect the electrical leads through a blood vessel into the heart. Unlike conventional pacemakers, CRT-Ps have two leads: one placed into the right ventricle and the other in the right atrium. An extra lead is implanted on the left side of the heart to stimulate the left ventricle, assisting the heart to pump efficiently.

For detailed report with TOC, please click here Global Cardiac Resynchronization Therapy Pacemaker Market 2016-2020.

Market Growth: The global cardiac resynchronization therapy-pacemaker (CRT-P) market is expected to grow at a CAGR of 8.17% during the period 2016-2020.

Key vendors: 
• Boston Scientific
• LivaNova
• Medtronic
• St. Jude Medical


Regions Covered: 

• Americas

Companies Mentioned

BIOTRONIK, Boston Scientific, LivaNova, Medtronic, St. Jude Medical


Debora White

Manager - Marketing

Ph: +1-888-789-6604

Reportstack Market Research